Are all grade group 4 prostate cancers created equal? Implications for the applicability of the novel grade grouping-Reference-Cited by-同舟云学术

Are all grade group 4 prostate cancers created equal? Implications for the applicability of the novel grade grouping

Published:2017-07 Issue:7 Volume:35 Page:461.e7-461.e14
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Gandaglia Giorgio,Karnes R. Jeffrey,Sivaraman Arjun,Moschini Marco,Fossati Nicola,Zaffuto Emanuele,DellʼOglio Paolo,Cathelineau Xavier,Montorsi Francesco,Sanchez-Salas Rafael,Briganti Alberto

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference25 articles.

1. A contemporary prostate cancer grading system: a validated alternative to the Gleason score;Epstein;Eur Urol,2016

2. Contemporary Gleason grading and novel grade groups in clinical practice;Magi-Galluzzi;Curr Opin Urol,2016

3. Grading of prostate cancer: past, present, and future;Matoso;Curr Urol Rep,2016

4. Changes in prostate cancer grading: including a new patient-centric grading system;Kryvenko;Prostate,2016

5. Acinar adenocarcinoma;Humphrey,2016

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study;Virchows Archiv;2024-04-29

2. Do Subgroup Evaluations Provide Additional Contributions to Biochemical Recurrence in Grade Group 4 and 5 Patients? A Multicenter Study by the Turkish Urooncology Association Prostate Cancer Working Group;The Bulletin of Urooncology;2024-04-04

3. Significance of the cribriform morphology area ratio for biochemical recurrence in Gleason score 4 + 4 prostate cancer patients following robot‐assisted radical prostatectomy;Cancer Medicine;2024-03

4. Prognosis of Gleason Score 9–10 Prostatic Adenocarcinoma in Needle Biopsies: A Nationwide Population-based Study;European Urology Oncology;2023-11

5. Heterogeneity of contemporary grade group 4 prostate cancer in radical prostatectomy specimens;World Journal of Urology;2022-11-07